melarsen: product of the decomposition in aqueous solution of melarsamine HCl; RN given refers to di-Na salt; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 79871 |
| MeSH ID | M0052088 |
| Synonym |
|---|
| melarsen |
| nsc10894 |
| nsc-10894 |
| antineoplastic-10894 |
| 5806-89-3 |
| [4-[(4,6-diamino-1,3,5-triazin-2-yl)amino]phenyl]arsonic acid |
| 4-((4,6-diamino-1,3,5-triazin-2-yl)amino)phenylarsonic acid |
| nsc 10894 |
| unii-fse56bh8xt |
| einecs 227-365-0 |
| fse56bh8xt , |
| (4-((4,6-diamino-1,3,5-triazin-2-yl)amino)phenyl)arsonic acid |
| DTXSID40206786 |
| (4-arsonophenyl)-1,3,5-triazine-2,4,6-triamine |
| arsonic acid, (4-((4,6-diamino-1,3,5-triazin-2-yl)amino)phenyl)- |
| arsanilic acid, n-(4,6-diamino-s-triazin-2-yl)- |
| 1,3,5-triazine-2,4,6-triamine, (4-arsonophenyl)- |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 6 (54.55) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 12 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||